2.1900
+0.0300
+(1.39%)
At close: January 24 at 4:00:01 PM EST
Insider Roster
Insider roster data is derived solely from the last 24 months of Form 3 & Form 4 SEC filings.
| Individual or Entity | Most Recent Transaction | Date | Shares Owned as of Transaction Date |
|---|---|---|---|
| ARBEL IRIT Director | Stock Award(Grant) | Dec 31, 2024 | 41,054 |
| BAIRU MENGHISTEAB M.D. Director | Stock Award(Grant) | Dec 31, 2024 | 24,000 |
| FRENKEL JACOB A. Director | Stock Award(Grant) | Dec 31, 2024 | 43,777 |
| HARTOUNIAN HARTOUN Chief Operating Officer | Stock Award(Grant) | Dec 31, 2024 | 52,000 |
| LEBOVITS CHAIM Chief Executive Officer | Stock Award(Grant) | Dec 31, 2024 | 334,349 |
| LINDBORG STACY R. PH.D. Director | Stock Award(Grant) | Dec 31, 2024 | 48,229 |
| NAOR NIR Director | Stock Award(Grant) | Dec 31, 2024 | 31,465 |
| PATLIS ALLA Chief Financial Officer | Stock Award(Grant) | Dec 31, 2024 | 44,349 |
| POLVERINO ANTHONY J Director | Stock Award(Grant) | Dec 31, 2024 | 25,730 |
| YABLONKA URI Officer and Director | Stock Award(Grant) | Dec 31, 2024 | 68,464 |
Related Tickers
BLRX BioLineRx Ltd.
0.1093
-5.69%
PLUR Pluri Inc.
4.4500
-1.11%
ALLK Allakos Inc.
1.2100
+17.48%
ADVM Adverum Biotechnologies, Inc.
4.4900
-0.44%
ZVSA ZyVersa Therapeutics, Inc.
1.4808
-1.93%
AIM AIM ImmunoTech Inc.
0.2141
-4.80%
CAMP CAMP4 THERAPEUTICS CORPORATION
5.11
-6.07%
ATXI Avenue Therapeutics, Inc.
1.8900
+2.72%
EDSA Edesa Biotech, Inc.
2.2300
+28.90%
ELEV Elevation Oncology, Inc.
0.6619
-0.09%